European Archives - Page 19 of 1006 - European Medical Journal

Avacopan Therapy Linked to Liver Injury in Patients With Vasculitis

Avacopan therapy for vasculitis carries a risk of liver injury, particularly in elderly and low-weight patients, highlighting the need for regular monitoring.

Hema Now: Episode 7: Decoding T Cells and Advancing Immunology

This week, Jonathan is joined by Dr Shahram Kordasti, Associate Professor in Applied Cancer Immunopathology at King’s College London, UK.

Researchers

Gene therapy from Novartis shows promise for children with SMA

Novartis’ Phase III study has demonstrated significant improvement in motor function in children and young adults with spinal muscular atrophy

Steroid Use Linked to Long-Term Coronary Microvascular Dysfunction

AAS use may cause persistent coronary microvascular dysfunction, even years after cessation, highlighting long-term cardiovascular risks.

Spoonful of technology: Nov-Dec 2024

Discover the latest examples of how pharma and its partners are working together to develop technology to solve key industry challenges.

Increased Cardiovascular Disease Risk in Cutaneous Lupus Erythematosus

Given these results, patients with cutaneous lupus erythematosus may benefit from increased vigilance in cardiovascular screening and management.

Telemedicine-Based Exercise Programme Shows Promise for Cancer Survivors

A recent study examining the effectiveness of a telemedicine-based exercise programme for cancer survivors has shown encouraging results…

CBD May Reduce Screening Anxiety in Women with Advanced Breast Cancer

Cannabidiol shown to help women experiencing anxiety before diagnostic scans.

Does IV Lidocaine Boost Postoperative Gut Function Recovery?

The ALLEGRO trial aimed to determine whether 2% IV lidocaine could speed up the return of gut function following colon resection surgery.

Enhancing Prostate Cancer Detection in Diverse Populations

Stockholm3 demonstrates significant potential to enhance prostate cancer detection in diverse populations while maintaining similar sensitivity to PSA.